Recent identification of the Rab proteins as targets of the Parkinson's disease kinase LRRK2 required the development of rabbit monoclonal antibodies to allow analysis of endogenous Rab phosphorylation in biological samples (Steger et al, 2017; Lis et al, 2018). The gene discussed is LRRK2; the disease is glycogen storage disease VI.